CA2491721A1 - Gastrointestinal compositions comprising gaba derivatives - Google Patents

Gastrointestinal compositions comprising gaba derivatives Download PDF

Info

Publication number
CA2491721A1
CA2491721A1 CA002491721A CA2491721A CA2491721A1 CA 2491721 A1 CA2491721 A1 CA 2491721A1 CA 002491721 A CA002491721 A CA 002491721A CA 2491721 A CA2491721 A CA 2491721A CA 2491721 A1 CA2491721 A1 CA 2491721A1
Authority
CA
Canada
Prior art keywords
mixtures
group
compositions
acid
rectal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002491721A
Other languages
English (en)
French (fr)
Inventor
Arthur Anthony Ciociola
Catherine Ann Segal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/193,640 external-priority patent/US20040010034A1/en
Priority claimed from US10/196,060 external-priority patent/US20040010035A1/en
Application filed by Individual filed Critical Individual
Publication of CA2491721A1 publication Critical patent/CA2491721A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002491721A 2002-07-10 2003-06-30 Gastrointestinal compositions comprising gaba derivatives Abandoned CA2491721A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/193,640 US20040010034A1 (en) 2002-07-10 2002-07-10 Gastrointestinal compositions
US10/193,640 2002-07-10
US10/196,060 US20040010035A1 (en) 2002-07-15 2002-07-15 Gastrointestinal compositions
US10/196,060 2002-07-15
PCT/IB2003/003156 WO2004006901A1 (en) 2002-07-10 2003-06-30 Gastrointestinal compositions comprising gaba derivatives

Publications (1)

Publication Number Publication Date
CA2491721A1 true CA2491721A1 (en) 2004-01-22

Family

ID=30117823

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002491721A Abandoned CA2491721A1 (en) 2002-07-10 2003-06-30 Gastrointestinal compositions comprising gaba derivatives

Country Status (7)

Country Link
EP (1) EP1549302A1 (ja)
JP (1) JP2005533100A (ja)
AU (1) AU2003247042A1 (ja)
BR (1) BR0312568A (ja)
CA (1) CA2491721A1 (ja)
MX (1) MXPA05000405A (ja)
WO (1) WO2004006901A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007505095A (ja) * 2003-09-12 2007-03-08 ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー うつ病及び不安障害の治療のためのアルファ−２−デルタリガンド及びｓｓｒｉ及び／又はｓｎｒｉを含む組み合わせ
US8060050B2 (en) 2004-06-04 2011-11-15 Broadcom Corporation Method and system for analog and digital RF receiver interface
ITMI20041447A1 (it) * 2004-07-20 2004-10-20 Zambon Spa Composizione farmaceutica comprendente gabapentina
CN107582521A (zh) * 2017-09-27 2018-01-16 江西省子轩科技有限公司 一种稳定性好的乙酰谷酰胺注射液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2460919A1 (fr) * 1979-07-11 1981-01-30 Prod Synthese Ste Indle Amino-ethers oxydes, leur procede de preparation et leur application en therapeutique
US5245080A (en) * 1989-02-20 1993-09-14 Jouveinal Sa (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-N-propylamine, process for preparing it and its therapeutical use
US6127418A (en) * 1997-08-20 2000-10-03 Warner-Lambert Company GABA analogs to prevent and treat gastrointestinal damage
AU8668598A (en) * 1997-08-20 1999-03-08 University Of Oklahoma, The Gaba analogs to prevent and treat gastrointestinal damage

Also Published As

Publication number Publication date
AU2003247042A1 (en) 2004-02-02
JP2005533100A (ja) 2005-11-04
BR0312568A (pt) 2005-05-03
EP1549302A1 (en) 2005-07-06
WO2004006901A1 (en) 2004-01-22
MXPA05000405A (es) 2005-03-23

Similar Documents

Publication Publication Date Title
US6986901B2 (en) Gastrointestinal compositions
RU2644635C2 (ru) Системы, способы и составы для лечения рака
JP2008524267A (ja) バニロイド受容体作用薬と神経再生物質阻害物質との混合物、鎮痛薬を生成するためのそれらの使用、および該鎮痛薬を適用する方法
PT95564B (pt) Processo para a preparacao de (+)-ibuprofen-d-aminoacido uteis como analgesicos intensificados de ataque acelerado
JP2010510973A (ja) 心筋組織の壊死を処置するためのホスホエノールピルビン酸誘導体の使用
US20050136127A1 (en) Gastrointestinal compositions
CA2385930A1 (en) Synergistic combinations of an nk1 receptor antagonist and a gaba structural analog
CA2491721A1 (en) Gastrointestinal compositions comprising gaba derivatives
US20040010034A1 (en) Gastrointestinal compositions
CA3033065A1 (en) Drug compositions
US20040010035A1 (en) Gastrointestinal compositions
MXPA05005707A (es) Uso de un agonista de receptor activado de proliferador de peroxisoma alfa y metformin para reducir los trigliceridos en el suero.
US20040009234A1 (en) Gastrointestinal compositions
ES2393128T3 (es) Ibuprofeno contra la tos
US20160000741A1 (en) Methods for Increasing Oral Osteogenesis Using Lipoxin A4 (LXA4) and Its Analogs
EA011309B1 (ru) Составы для ослабления боли, содержащие целекоксиб
CA3104916C (en) Pharmaceutical composition for preventing diabetes and use thereof
JP2005538098A (ja) ヘムオキシゲナーゼレベルの上昇を必要とする治療上の処置におけるレインの使用
US3852454A (en) Treatment of rheumatoid arthritis
JP2007077116A (ja) 臓器線維化抑制剤
NL2022615B1 (en) Pharmaceutical composition comprising tetrahydrocannabivarin for the prevention and treatment of overweight
JP2005503346A (ja) 片頭痛を治療するための方法及び組成物
US20050059741A1 (en) Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-1
JPH03115220A (ja) 非心臓由来の不整脈防止薬

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead